Status:
WITHDRAWN
Ultra-sound Assisted Management of Heart Failure
Lead Sponsor:
The University of Texas Medical Branch, Galveston
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the impact of using hand carried ultrasound measurements of volume status in directing treatment of heart failure patients admitted with acute exacerbation.
Detailed Description
The purpose of this study is to evaluate the impact of using hand carried ultrasound measurements of volume status in directing treatment of heart failure patients admitted with acute exacerbation. Th...
Eligibility Criteria
Inclusion
- New admission from emergency department to heart failure ( red team) service for acute exacerbation of heart failure ( defined based on clinical and imaging characteristics , shortness of breath due to volume overload, CXR showing pulmonary vascular congestion/pulmonary edema, elevated NTproBNP, dyspnea Not secondary to infectious process (pneumonia).
- Heart failure NYHA class III, IV
- Age\>=18 years old
Exclusion
- End stage Renal disease on dialyses (ESRD on HD) or stage V CKD (defined as GFR\<15)
- end stage Heart failure on chronic inotrope (example Milrinone)
- Renal failure that deemed to be secondary to other reason (dehydration, renal or post renal (obstructive)
- morbid obesity BMI \> 40
- incarcerated patients (prison) TDC.
- pregnant patients
- Patients with dyspnea not mainly due to heart failure, ESRD patients, intubated patients
- Aged less than 18 years.
Key Trial Info
Start Date :
November 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 17 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04376424
Start Date
November 1 2021
End Date
November 17 2021
Last Update
November 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Medical Branch
Galveston, Texas, United States, 77555